Emulate files details on its $12 million financing


Emulate raised $12 million from four financial backers on July 11th according to information disclosed by the company. The non-brokered equity offering was fully subscribed. No offering was previously initiated by the company under a registration exemption with the SEC.

Emulate commercializes an automated ‘Organs-on-Chips’ platform that mimics human physiology and diseases, while permitting real-time elucidation of molecular mechanisms of action and toxicity. The company is backed by NanoDimension, Cedars-Sinai Medical Center and private investor Hansjörg Wyss.

The company was registered in 2013 and has its headquarters located in Cambridge MA. Emulate elected to keep its revenues undisclosed.
The executive team includes Daniel Levner, David James Coon, Geraldine A Hamilton and Gregory D Williams.
The board of directors includes Eric Moessinger and Hansjoerg Wyss.

Offering recap
Status: Completed
Company: Emulate
Industry: Biotechnology
Amount offered: $12 million
Amount placed: $12 million
First sale: 07-11-2014
Data as of: 07-28-2014
For more information visit www.XDATA.co

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s